nicotine has been researched along with n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayers, JT; Crooks, PA; Deaciuc, AG; Dwoskin, LP; Grinevich, VP; Zhu, J | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Neugebauer, NM; Zhang, Z | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Neugebauer, NM; Rahman, S; Zhang, Z | 2 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Papke, RL; Rahman, S; Zhang, Z | 1 |
| Ayers, JT; Bardo, MT; Crooks, PA; Deaciuc, AG; Dwoskin, LP; Joyce, BM; Lockman, PR; Manda, VK; McIntosh, JM; Siripurapu, KB; Sumithran, SP; Wooters, TE; Zhang, Z | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Crooks, PA; Dhawan, GK; Dwoskin, LP; Siripurapu, KB; Smith, AM; Zhang, Z | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; McIntosh, JM; Pivavarchyk, M; Smith, AM; Wooters, TE; Zhang, Z; Zheng, G | 1 |
9 other study(ies) available for nicotine and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide
| Article | Year |
|---|---|
bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Aza Compounds; Binding, Competitive; Brain; In Vitro Techniques; Indicators and Reagents; Ligands; Magnetic Resonance Spectroscopy; Neurons; Nicotinic Antagonists; Quaternary Ammonium Compounds; Rats; Receptors, Nicotinic; Rubidium Radioisotopes; Structure-Activity Relationship; Synaptosomes; Thalamus | 2002 |
Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
Topics: Animals; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Infusions, Intravenous; Injections, Subcutaneous; Male; Mecamylamine; Motivation; Motor Activity; Nicotine; Nicotinic Antagonists; Picolines; Premedication; Rats; Rats, Sprague-Dawley; Self Administration; Sucrose | 2006 |
The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.
Topics: Amphetamine; Analysis of Variance; Animals; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Electrochemistry; Extracellular Fluid; Male; Nicotine; Nicotinic Antagonists; Nucleus Accumbens; Picolines; Rats; Rats, Sprague-Dawley | 2007 |
Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
Topics: Acetylcholine; Animals; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mecamylamine; Membrane Potentials; Microdialysis; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Perfusion; Picolines; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recombinant Proteins; Time Factors; Ventral Tegmental Area; Xenopus laevis | 2008 |
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
Topics: Animals; Behavior, Animal; Biological Transport, Active; Blood-Brain Barrier; Corpus Striatum; Discrimination Learning; Dopamine; Male; Molecular Structure; Motor Activity; Nerve Tissue Proteins; Nicotine; Nicotinic Antagonists; Picolines; Plasma Membrane Neurotransmitter Transport Proteins; Protein Binding; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Structure-Activity Relationship | 2008 |
The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Picolines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2008 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
Topics: Aconitine; Allosteric Regulation; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Picolines; Rats; Rats, Sprague-Dawley; Tritium | 2009 |
Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.
Topics: Animals; Corpus Striatum; Dopamine; Drug Synergism; In Vitro Techniques; Male; Nicotine; Nicotinic Antagonists; Picolines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2010 |